Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid
NOVA1
Wirt: Synthetic
BP, WB, IHC
Kurzübersicht für Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid (ABIN5615031)
Target
NOVA1
(Neuro-Oncological Ventral Antigen 1 (NOVA1))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Sequenz
- SKKGEFVPGT RNRKVTITGT PAATQAAQYL ITQRITYEQG VRAANPQKVG
-
Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA1 antibody, catalog no. 70R-4832
-
-
Neuro-Oncological Ventral Antigen 1 (NOVA1) peptide
NOVA1 Reaktivität: Human Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
Target
-
Sie sind hier:
